SEACOR Holdings Inc. and American Industrial Partners Announce Closing of Tender Offer

SEACOR Holdings Inc. and American Industrial Partners Announce Closing of Tender Offer

NEW YORK–(BUSINESS WIRE)–
SEACOR Holdings Inc. (NYSE: CKH) (“SEACOR”) and American Industrial Partners and its affiliate Safari Merger Subsidiary, Inc. (“Purchaser”) announced that Purchaser has successfully completed its tender offer for the outstanding shares of common stock of SEACOR and accepted for payment all shares validly tendered and not withdrawn as of the expiration time of the tender offer. 70.4% of outstanding shares were tendered into the offer. All of the shares tendered have been accepted for payment by Purchaser.

On December 4, 2020, SEACOR and American Industrial Partners announced that SEACOR and an affiliate of American Industrial Partners had entered into a definitive merger agreement. Pursuant to the merger agreement, Purchaser, a corporation controlled by affiliates of American Industrial Partners, commenced a tender offer on December 18, 2020 to acquire all outstanding shares of SEACOR at a price of $41.50 per share, net to the holder in cash. The tender offer expired at 5:00 p.m., Eastern Time, on April 14, 2021, and American Stock Transfer & Trust Company, LLC, the depository for the tender offer, has indicated that a total of approximately 14,472,289 shares, representing approximately 70.4% of the outstanding shares, had been validly tendered pursuant to the offer.

Pursuant to the terms of the merger agreement, as soon as practicable following the consummation of the tender offer, Purchaser will be merged with and into SEACOR with SEACOR continuing as the surviving corporation. In the merger, each share not previously purchased in the tender offer that is outstanding immediately prior to the effective time (other than shares held by stockholders who properly exercised their appraisal rights under Delaware law) will be converted into the right to receive $41.50 per share, net to the seller in cash. As a result of the completion of the merger, SEACOR’s common stock will cease trading on The New York Stock Exchange.

Foros is acting as financial advisor to SEACOR. Milbank LLP is acting as legal advisor to SEACOR and Ropes & Gray LLP is acting as legal advisor to American Industrial Partners and Purchaser.

About SEACOR Holdings

SEACOR Holdings Inc. is a diversified holding company with interests in domestic and international transportation and logistics, crisis and emergency management, and clean fuel and power solutions.

About American Industrial Partners

American Industrial Partners is an operationally oriented private equity firm that invests in industrial businesses serving domestic and global markets. The firm has deep roots in the industrial economy and has been active in private equity investing since 1989. To date, American Industrial Partners has completed more than 100 transactions and currently has more than $8 billion of assets under management on behalf of leading pension, endowment and financial institutions. For more information on American Industrial Partners, visit www.americanindustrial.com.

Information Agent Contact

Michael Madalon

D.F. King & Co., Inc.

212-269-5732 / 917-294-9326

[email protected]

Investor Contact

Innisfree M&A Incorporated

Scott Winter / Jonathan Salzberger

212-750-5833

Media Contact

Stephen Pettibone / Mike DeGraff

Sard Verbinnen & Co.

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Other Professional Services Transport Logistics/Supply Chain Management Finance Other Transport

MEDIA:

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

Bio-Rad to Report First-Quarter 2021 Financial Results, Thursday, April 29, 2021

HERCULES, Calif.–(BUSINESS WIRE)–
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2021 on Thursday, April 29, 2021, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., passcode: 4692298. You may also listen to the conference call live via a webcast that is available on the “Investor Relations” section of our website under “Quarterly Results” at bio-rad.com. The webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,800 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020. Please visit bio-rad.com for further information.

Investor Contact:

Bio-Rad Laboratories, Inc.

Ilan Daskal, Executive Vice President

& Chief Financial Officer

510-724-7000

[email protected]

Media Contact:

Bio-Rad Laboratories, Inc.

Tina Cuccia, Manager, Corporate Communications

510-741-6063

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Science Biotechnology Research Pharmaceutical Managed Care Medical Supplies Health Hospitals

MEDIA:

Logo
Logo

Progressive Water Treatment Today Launches ‘BroncBoost’™, the Texas Sized Booster Pump Station for Commercial Water Distribution Systems

Progressive Water Treatment Today Launches ‘BroncBoost’™, the Texas Sized Booster Pump Station for Commercial Water Distribution Systems

BroncBoost is a key large-scale dewatering solution for crisis areas like Tampa Bay’s Piney Point

DALLAS–(BUSINESS WIRE)–OriginClear Inc. (OTC Pink: OCLN), The Water Company for the New Economy™, announces today that its Progressive Water Treatment division (www.progressivewater.com) is now shipping BroncBoost™, its workhorse Booster Pump Station equipment line. Engineered and built in Texas, BroncBoost allows customersto control water flow rates and pressure for mission critical water distribution systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210415005366/en/

The BroncBoost™ Booster Pump Stations from Progressive Water Treatment, Inc. are designed to provide the end user with a superior solution to the repressurization requirements of their respective process application. Our goal is to provide the best quality product at the best possible price, without cutting corners when it comes to quality of components. (Photo: Business Wire)

The BroncBoost™ Booster Pump Stations from Progressive Water Treatment, Inc. are designed to provide the end user with a superior solution to the repressurization requirements of their respective process application. Our goal is to provide the best quality product at the best possible price, without cutting corners when it comes to quality of components. (Photo: Business Wire)

BroncBoost delivers reliable pumping capability and pressure control in an efficiently designed package to meet the demanding needs of commercial end-users, such as hotels and resorts, residential development projects, mixed use commercial sites, institutional facilities, manufacturing, agriculture, and much more. It offers Standard and High-Volume pumping options for owners requiring robust on-site water conveyance solutions.

Consolidated Water Solutions of Nebraska is a trusted distribution partner who deployed BroncBoost at a mining operation in the Pacific Northwest for onsite dewatering. “The Dewatering project needed a reliable booster pump station to work in a rugged environment. The BroncBoost provided reliable water pressure and a steady feed for the ultra-filtration and reverse osmosis systems to perform a safe and repeatable process,” said Jim Davis of Consolidated Water Solutions. “These installed units allow for the integration of additional pump skids in the event of a future expansion to pressurize and improve flow rates.”

Progressive Water Treatment’s factory performance-tested booster package delivers as a “Plug and Play” unit with the entire system pre-wired, piped, and pressure tested to ensure proper operation once installed and commissioned at the customer’s site. The BroncBoost Model BB-500M offers a powerful 200 GPM to 500 GPM “kick” in an attractively priced package. The full product line offers five pumping capabilities with flows ranging from 1 GPM to 750 GPM.

BroncBoost™ Booster Pump Stations are a skid-mounted booster pump system used to assist undersized and chronic low-pressure distribution systems achieve their necessary flow and pressure conditions during peak demand periods. While BroncBoost in its standard form is an exceptional value, there are available options for customers needing a more advanced booster station. Epoxy coated steel skid frame systems, 304 and 316 stainless steel piping, and stainless steel NEMA 4X electrical control enclosures provide enhanced corrosion resistance. With the Integration of digital pressure and flow sensors combined with Programmable Logic Controllers (PLCs), operators can track, monitor, and optimize their entire pumping process with ease. Remote monitoring using smart-phone and tablet interface systems are also available.

“The BroncBoost is an extremely versatile piece of equipment and a vital component for systems like a Dewatering Solution where water consistent and reliable flow and pressure delivery criteria are absolutely crucial for success, “said, Dan Early, OriginClear CTO. “Systems like this are used for scenarios like or could even be a part of what is needed to help clean and process the water near Tampa at Piney Point.”

For more information on the BroncBoost™, please follow www.progressivewater.com/broncboost.

Progressive Water Treatment, Inc. – a division of OriginClearTech.

Progressive Water Treatment, Inc. designs and manufactures water treatment systems for municipal, industrial, and pure water applications. The company utilizes a wide range of technologies, including chemical injection, media filters, membrane, ion exchange and SCADA (supervisory control and data acquisition) technology in turnkey systems.

Progressive Water Treatment offers a broad range of services including maintenance contracts, retrofits, and replacement assistance. In addition, PWT rents equipment in contracts of varying duration. Customers are primarily served in the United States and Canada, with the company’s reach extending worldwide from Japan to Argentina to the Middle East.

Progressive Water Treatment focuses on power, industrial, municipal, and Ultrapure Water markets. It is a key solution builder within the OriginClear Tech group of brands providing leading-edge technologies aimed to solve today’s toughest challenges.

Progressive Water Treatment, Inc. is a division of OriginClear Tech and celebrates 25 Years in business and maintains manufacturing facilities near Dallas, Texas.

For more information, visit the company’s website: www.progressivewater.com

Follow us onTwitter

Follow us onLinkedIn

Like us onFacebook

Signup for ourNewsletter

OriginClearTech is a subsidiary of OriginClear, Inc. OTC PINK: OCLN

OriginClear Safe Harbor Statement:

Matters discussed in this presentation contain forward-looking statements. When used in this update, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with our history of losses and our need to raise additional financing, the acceptance of our products and technology in the marketplace, our ability to demonstrate the commercial viability of our products and technology and our need to increase the size of our organization. Further information on the Company’s risk factors is contained in the Company’s quarterly and annual reports as filed with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason except as may be required under applicable law. There cannot be any assurance that our agreement with Philanthroinvestors, Inc. will enable us to generate any revenue.

Investor Relations OriginClear:

Devin Angus

Toll-free: 877-999-OOIL (6645) Ext. 3

International: +1-323-939-6645 Ext. 3

Fax: 323-315-2301

[email protected]

www.OriginClear.com

Press Contact:

Adrienne Mazzone

TransMedia Group

+1 561-908-1683

[email protected]

www.transmediagroup.com

KEYWORDS: United States North America Texas

INDUSTRY KEYWORDS: Manufacturing Other Manufacturing Energy Engineering Utilities

MEDIA:

Photo
Photo
The BroncBoost™ Booster Pump Stations from Progressive Water Treatment, Inc. are designed to provide the end user with a superior solution to the repressurization requirements of their respective process application. Our goal is to provide the best quality product at the best possible price, without cutting corners when it comes to quality of components. (Photo: Business Wire)
Logo
Logo
Logo
Logo

Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI

Perimeter Medical Imaging AI Receives U.S. FDA Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI

New designation provides potential pathway to expedite adoption of Perimeter’s transformative medical imaging technology combined with artificial intelligence

TORONTO–(BUSINESS WIRE)–
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced today that the U.S. Food and Drug Administration (FDA) has granted the company a Breakthrough Device Designation for its Optical Coherence Tomography (OCT) Imaging System coupled with ImgAssist AI. Perimeter is advancing its proprietary, next-gen artificial intelligence technology and machine learning tools through clinical development under its ATLAS AI project, which is made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT), a leading state body funding cancer research.

The goal of the FDA’s Breakthrough Devices Program is to provide patients and health care providers with timely access to medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions by speeding up their development, assessment, and review. This designation allows for accelerated interactions with the FDA during product development and prioritized review of future regulatory submissions. In addition, a new Medicare policy program (Medicare Coverage of Innovative Technology, or MCIT) provides national Medicare coverage for up to four years for FDA-designated Breakthrough Devices upon market authorization, enabling more rapid utilization of new and innovative technologies for the Medicare population.

Liz Munro, Perimeter’s co-founder and President of Canadian Operations commented, “Since company inception, the Perimeter team’s vision has been to develop imaging tools that have the potential to improve outcomes for clinicians, payors and most importantly – patients and their families. We are thrilled that FDA has granted Breakthrough Device Designation for our OCT Imaging System with ImgAssist AI, recognizing the potential of our device to offer significant advantages over existing alternatives for intra-operative evaluation of margins during breast cancer lumpectomy. We are grateful to the FDA review team for our productive interactions, as well as their timely review of this submission, and look forward to working with FDA through the final stages of development and clinical validation of this exciting product.”

Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Achieving a Breakthrough Device Designation from the FDA further validates our strong belief that Perimeter’s novel OCT Imaging System combined with AI has the potential to be a transformative, disruptive new technology aimed at helping surgeons treat breast cancer. This Breakthrough Designation, combined with the Centers for Medicare & Medicaid Services’ (CMS) initiatives around MCIT, have the potential to provide a pathway to expediting adoption of this innovative technology. We are committed to providing physicians with ultra-high-resolution images of excised breast tissue ‘real-time’ during a surgical procedure combined with added artificial intelligence tools to help them interpret areas suspicious for cancer, with the goal of improving patient outcomes and lowering healthcare costs.”

About Perimeter Medical Imaging AI, Inc.

Perimeter Medical Imaging AI (TSX-V:PINK)(OTC:PYNKF)(FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing and commercializing advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter’s Optical Coherence Tomography (OCT) Imaging System provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen. The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter’s OCT Imaging System is cleared by the FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is advancing its proprietary, next-gen artificial intelligence technology and machine learning tools through clinical development under its ATLAS AI project, which is made possible, in part, by a $7.4 million grant awarded by the Cancer Prevention and Research Institute of Texas (CPRIT). Perimeter’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month by the Canadian Cancer Society and the American Cancer Society, driving home the company’s dedication to helping surgeons, radiologists and pathologists use Perimeter’s imaging technology and AI in the fight against breast cancer, which is estimated to account for 30% of all female cancer diagnoses this year.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains statements that may constitute “forward-looking information” within the meaning of applicable Canadian securities legislation. In this news release, words such as “may”, “would”, “could”, “will”, “likely”, “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate” and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management’s future outlook and anticipated events or results, and may include statements or information regarding the timing of and results from clinical studies, the clinical development of Perimeter’s ImgAssist AI technology, the commercialization of Perimeter’s OCT Imaging System, the impact of FDA Breakthrough Designation on future regulatory submissions or Medicare approvals, future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, financial results, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding potential future development and commercialization activities are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management’s good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Perimeter’s control. Such forward-looking statements reflect Perimeter’s current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter’s financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described the joint information circular dated May 12, 2020, prepared in respect of the securityholder meetings held on June 17, 2020 a copy of which is available on Perimeter’s SEDAR profile at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. In particular, we note the risk that our technology may not achieve the anticipated benefits in terms of surgical outcomes. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.

Jodi Regts

Corporate Communications / Investor Relations

Perimeter Medical Imaging AI, Inc.

+1 778-999-5634

[email protected]

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Oncology Health FDA Medical Devices Surgery Radiology Biotechnology

MEDIA:

Logo
Logo

BlackRock TCP Capital Corp. Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2021

BlackRock TCP Capital Corp. Schedules Earnings Release and Conference Call for the First Quarter Ended March 31, 2021

SANTA MONICA, Calif.–(BUSINESS WIRE)–
BlackRock TCP Capital Corp. (NASDAQ: TCPC) announced today that it will report its financial results for the first quarter ended March 31, 2021 on Wednesday, May 5, 2021, prior to the opening of the financial markets.

BlackRock TCP Capital Corp. will host a conference call at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) on Wednesday, May 5, 2021 to discuss its financial results.

All interested parties are invited to participate in the conference call by dialing (866) 270-1533; international callers should dial (412) 317-0797. The conference call will be webcast simultaneously in the investor relations section of TCPC’s website at http://investors.tcpcapital.com. An archived replay of the call will be available approximately two hours after the live call, through May 12, 2021. For the replay, please visit https://investors.tcpcapital.com/events-and-presentations or dial (877) 344-7529. For international replay, please dial (412) 317-0088. For all replays, please reference access code 10154439.

ABOUT BLACKROCK TCP CAPITAL CORP.:

BlackRock TCP Capital Corp. (NASDAQ: TCPC) is a specialty finance company focused on direct lending to middle-market companies as well as small businesses. TCPC lends primarily to companies with established market positions, strong regional or national operations, differentiated products and services and sustainable competitive advantages, investing across industries in which it has significant knowledge and expertise. TCPC’s investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. TCPC is a publicly traded business development company, or BDC, regulated under the Investment Company Act of 1940 and is externally managed by its advisor, Tennenbaum Capital Partners, LLC, a wholly owned, indirect subsidiary of BlackRock, Inc. For more information, visit www.tcpcapital.com.

FORWARD-LOOKING STATEMENTS

Prospective investors considering an investment in BlackRock TCP Capital Corp. should consider the investment objectives, risks and expenses of the Company carefully before investing. This information and other information about the Company are available in the Company’s filings with the Securities and Exchange Commission (“SEC”). Copies are available on the SEC’s website at www.sec.gov and the Company’s website at www.tcpcapital.com. Prospective investors should read these materials carefully before investing.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on estimates, projections, beliefs and assumptions of management of the Company at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, changes in general economic conditions or changes in the conditions of the industries in which the Company makes investments, risks associated with the availability and terms of financing, changes in interest rates, availability of transactions, and regulatory changes. Certain factors that could cause actual results to differ materially from those contained in the forward-looking statements are included in the “Risk Factors” section of the Company’s Form 10-K for the year ended December 31, 2020, and the Company’s subsequent periodic filings with the SEC. Copies are available on the SEC’s website at www.sec.gov and the Company’s website at www.tcpcapital.com. Forward-looking statements are made as of the date of this press release and are subject to change without notice. The company has no duty and does not undertake any obligation to update or revise any forward-looking statements based on the occurrence of future events, the receipt of new information, or otherwise.

BlackRock TCP Capital Corp.

Katie McGlynn

310-566-1094

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Finance Consulting Banking Accounting Professional Services

MEDIA:

Logo
Logo

Joseph Osha Joins Guggenheim Securities as Senior Energy and Industrial Technology Analyst

NEW YORK, April 15, 2021 (GLOBE NEWSWIRE) — Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joseph Osha has joined the firm as a Managing Director and Senior Research Analyst covering the energy technology and industrial technology sectors with a focus on renewables.

Mr. Osha joins Guggenheim from JMP Securities, most recently serving as a Senior Equity Research Analyst covering the industrial technology and energy technology sectors. Prior to JMP, he was the Chief Financial Officer for GreenFire Energy and before that the Chief Financial Officer for Gravity Renewables. Mr. Osha began his career with nearly two decades of experience in equity research at Bank of America Merrill Lynch.

“We are excited to have Joe join Guggenheim,” said Stefano Natella, Head of Equities for Guggenheim Securities. “He will be a great addition to our equity research department, bringing deep sector expertise and market knowledge to contribute significantly to our existing technology equity research platform. We look forward to his continued success at Guggenheim.”

Mr. Osha is a CFA Charterholder. He received his M.B.A and M.A. in East Asian Area Studies from the University of Michigan and his B.S. in Business Administration from the University of Richmond. He is based in Guggenheim’s San Francisco office.

About Guggenheim Securities        

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers services that fall into four broad categories: Advisory, Financing, Sales and Trading, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Chicago, Boston, Atlanta, San Francisco, and Houston. For more information, please contact us at [email protected] or 212.518.9200.

About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $310 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With over 2,400 professionals based in offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.

1Assets under management are as of 12.31.2020 and include consulting services for clients whose assets are valued at approximately $70bn.

Media Contact

Steven Lee      

Guggenheim Partners
212.293.2811
[email protected]



Paul Kwan Joins General Catalyst as Managing Director

Former Head of West Coast Tech Banking at Morgan Stanley Further Strengthens GC’s Full-Stack Capabilities to Support Founders at Every Stage of Company Building

SAN FRANCISCO, April 15, 2021 (GLOBE NEWSWIRE) — Today, the venture capital firm General Catalyst (GC) announced that Paul Kwan, the former head of west coast tech banking at Morgan Stanley, has joined the firm as a managing director focused on identifying, building, and investing in enduring businesses in both the private and public markets.

For 25 years, Paul has partnered with category-defining tech companies to understand their strategic business objectives and ensure they have access to the capital required to meet those critical milestones. During his time at Morgan Stanley, he led IPOs and M&A for leading technology companies globally and helped create the modern day direct listing. Most recently, together with Morgan Stanley and GC, he created the first Stakeholder Aligned Initial Listing (SAlL™), the first SPAC structure in the market that aligns financial outcomes with the interests of all stakeholders. Paul has worked with a number of GC-backed companies during his tenure at Morgan Stanley, including representing Livongo in its $18.5 billion merger with Teladoc Health, the largest in digital health history to-date.

“Paul has built a strong reputation as the partner for stand-out tech companies looking to make a lasting impact,” said Hemant Taneja, managing partner, General Catalyst. “He’s adept at understanding the needs of those companies, collaborating with them to market themselves, and identify and acquire the strategic capital to lead in their respective sectors. That level of talent and instinct is invaluable to our portfolio companies as they navigate growth in both the private and public markets.”

Paul is well known and respected among founders and investors alike. At GC, he will focus on supporting and investing in software and internet companies, as well as digital Health Assurance companies both in the U.S. and abroad.

“I’m thrilled to join GC as they continue their evolution to a full-stack venture model”, said Paul Kwan. “Their commitment to supporting founders at every stage of the company building process while also making an impact on society is inspiring. In today’s world of digital transformation, companies are getting bigger faster. I’m excited to partner with GC portfolio companies and help guide them as they scale into and through the private and public markets responsibly and purposefully on their journey to becoming enduring businesses.”

About General Catalyst
General Catalyst is a venture capital firm that invests in powerful, positive change that endures — for our entrepreneurs, our investors, our people, and society. We support founders with a long-term view who challenge the status quo, partnering with them from seed to growth stage and beyond to build companies that withstand the test of time. With offices in San Francisco, Palo Alto, New York City, and Boston, the firm has helped support the growth of businesses such as: Airbnb, Deliveroo, Guild, Gusto, Hubspot, Illumio, Lemonade, Livongo, Oscar, Samsara, Snap, Stripe, and Warby Parker. For more: www.generalcatalyst.com.



Mercer Park Brand Acquisition Corp. Announces Proposed Extension to Facilitate the Completion of its Qualifying Transaction with GH Group, Inc. and Finalized Applicable Redemption Amount per Share

TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Mercer Park Brand Acquisition Corp. (NEO: BRND.A.U; OTCQX: MRCQF), a Special Purpose Acquisition Company (SPAC) which has entered into a definitive agreement to merge with GH Group, Inc. (the “Glass House Group Transaction”), California’s leading fully-integrated cannabis business, with the right to combine with a state-of-the-art greenhouse and 17 additional dispensary locations that are in the process of applying for licenses, announced today that it is seeking a brief extension in its permitted timeline, from May 13, 2021 to July 30, 2021, to enable the Glass House Group transaction to be completed. Subject to the satisfaction or waiver of the conditions of closing, the Glass House Group transaction is currently anticipated to close in the first half of June 2021.

A virtual meeting of the holders of Class A Restricted Voting Shares of Mercer Park Brand Acquisition Corp. (BRND) is scheduled to be held on May 5, 2021 at 10:00 am (Toronto time). In connection with the meeting, holders of Class A Restricted Voting Shares are being provided with the opportunity to deposit for redemption all or a portion of their Class A Restricted Voting Shares, irrespective of whether such holders vote for or against, or do not vote on, the extension resolution, provided that they deposit (and do not validly withdraw) their Class A Restricted Voting Shares for redemption prior to 5:00 p.m. (Toronto time) on April 28, 2021, which is the fifth business day before the date of the meeting.

BRND has updated and finalized its determination of the redemption amount per share to take into account the latest information available to it. BRND now estimates that the amount is approximately US$10.11 per Class A Restricted Voting Share, replacing the US$10.06 per share previously disclosed in the Management Information Circular dated April 5, 2021. The increase relates to an expected tax refund associated with the filing of the fiscal year 2020 income tax return, which was filed on April 14, 2021.

If the extension resolution is approved and the extension is made effective by the Board (which effectiveness would be announced by BRND at that time) BRND shall (a) redeem those Class A Restricted Voting Shares that are deposited (and not validly withdrawn) for redemption, and (b) deliver to each such holder its pro rata portion of the escrow funds available in BRND’s escrow account less certain specified costs. The remainder of the escrow funds shall remain in the escrow account and be available for use by BRND to complete its proposed qualifying acquisition on or before July 30, 2021. The meeting date for the shareholders’ meeting to approve the Glass House Group Transaction is expected to be in late May or early June. Further details of that meeting will be made available in due course.

Holders of Class A Restricted Voting Shares who do not redeem their Class A Restricted Voting Shares will retain their redemption rights and their ability to vote on the qualifying transaction through to July 30, 2021 if the extension resolution is approved and the extension is then made effective.

If the extension resolution is not approved and closing has not occurred by May 13, 2021, then, subject to applicable laws, each Class A Restricted Voting Share will be redeemed for its pro rata portion of the escrow funds available in BRND’s escrow account less certain specified amounts.

The Board may revoke the extension resolution without further approval of Class A Restricted Voting Shareholders of BRND at any time prior to the extension becoming effective in the event that the Board determines not to proceed with the extension.

The record date for the determination of registered holders of Class A Restricted Voting Shares of BRND entitled to receive notice of, and to vote at, the meeting is the close of business on April 5, 2021 (the “Record Date”). Only holders of Class A Restricted Voting Shares whose names are entered in BRND’s register of shareholders as of the close of business on the Record Date will be entitled to receive notice of, and to vote their shares at, the meeting. Registered holders of Class A Restricted Voting Shares of BRND and duly appointed proxyholders will be able to virtually attend, participate, vote and ask questions at the meeting online at web.lumiagm.com/208295271. Class A Restricted Voting Shareholders will not be able to attend the meeting in person. Beneficial holders of Class A Restricted Voting Shares of BRND (being shareholders who hold their shares through a securities dealer or broker, bank, trust company or trustee, custodian, nominee or other intermediary), who have not duly appointed themselves as their proxy will be able to virtually attend the meeting only as guests and to listen to the webcast but not be able to participate, ask questions or vote at the meeting.

The management information circular (the “Circular”) being sent to shareholders contains a detailed description of the extension and other information relating to BRND. We urge you to consider carefully all of the information in the Circular. Shareholders who have any questions or need additional information with respect to the voting of their Class A Restricted Voting Shares should consult their financial, legal, tax or other professional advisors.

About Mercer Park Brand Acquisition Corp.

Mercer Park Brand (“BRND”) is a special purpose acquisition corporation launched in May 2019 to create the leading branded cannabis company in the U.S. For more information about BRND, please visit the BRND website at www.mercerparkbrand.com.

About GH Group, Inc.

Glass House Group is a rapidly growing, vertically integrated, California-focused organization that strives every day to realize its vision of excellence: compelling cannabis brands, produced sustainably, for the benefit of all. Led by a team of expert operators, proven businesspeople, and passionate plant lovers, it is dedicated to delivering rich cannabis experiences with respect for people, for the environment, and for the community, and an abiding commitment to justice, social equity, and sustainability.

Company Contact:

Megan Kulick
T: (646) 977-7914
Email: [email protected]

Investor Relations Contact:

Cody Slach
Gateway Investor Relations
T: (949) 574-3860
Email: [email protected]



Assure Holdings Announces Acquisition of Elevation

DENVER, April 15, 2021 (GLOBE NEWSWIRE) — Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (“IONM”), is pleased to announce that effective March 15, 2021, and taking the form of an asset purchase agreement, it acquired the assets of (the “Acquisition”) Elevation EP, LLC (“Elevation”), a Texas-based IONM service provider. Assure acquired Elevation’s contracts, employees, business relationships and assets.

Elevation’s operations are based in the Dallas-Ft. Worth area of Texas. In 2020, Elevation performed approximately 550 IONM procedures and approximately 55% of these procedures were commercial insurance payors. Elevation employed two technologists supporting two surgeons at one facility.

“The Acquisition is consistent with our strategic plan to accelerate scale by augmenting the Company’s organic growth with selective M&A opportunities,” said John A. Farlinger, Assure’s executive chairman and CEO. “Elevation has established strong surgeon relationships and shares Assure’s commitment to providing superior IONM services.”

Farlinger added, “We will continue to be opportunistic and active in the M&A market. The Company expects to identify additional IONM assets we believe we can make more valuable on Assure’s platform, leveraging our strength in revenue cycle management and other functional areas.”

Farlinger concluded, “This Acquisition expands our presence in Texas, and we expect to leverage our scale in the state to negotiate new in-network agreements with payors in the local market. We also anticipate tapping into new business opportunities as a result of this transaction.”

“We are proud of the business we have built at Elevation and sought to join Assure given our shared alignment in providing clinical excellence for surgeons and standard of care safety for patients,” said Darla Holder, Elevation’s owner. “With the scale, resources and expertise Assure provides, I am excited about our ability to expand in Texas on a go-forward basis.”

About Assure Holdings

Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commission’s Gold Seal of Approval®. For more information, visit the Company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements

This news release contains certain statements that may constitute forward-looking information and forward-looking statements under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance or achievements that Assure anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information and forward-looking statements. Such information or statements may include, but is not limited to, comments with respect to strategies; expectations; planned operations; future actions of the Company; the reputation of Elevation in the IONM industry; the Acquisition will reinforce the Company’s strategic growth plan; the Acquisition will accelerate the Company’s growth, provide the Company with new business opportunities and negotiate new in-network agreements with payors in Texas. Often, but not always, forward-looking information or forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results “may”, “could”, “would”, “might” or “will” (or other variations of the forgoing) be taken, occur, be achieved, or come to pass. Forward-looking information and forward-looking statements are based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of Assure to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information and the forward-looking statements. Material risk factors include, but are not limited to the following: future capital requirements; growing competition in the IONM industry; the Acquisition may not result in the creation of new business opportunities for the Company; the Acquisition may not allow the Company to negotiate new in-network agreements with payors in Texas and expand its operations in the state; the Company may not continue to be active in the M&A market the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general; that the Company’s actions taken during the COVID-19 health crisis will be effective; and the risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements in this news release speak only as of the date of this release and Assure undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact

Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
[email protected]

 



PGIM Investments expands active fixed income ETF lineup with launch of core bond fund

PGIM Investments expands active fixed income ETF lineup with launch of core bond fund

PGIM Active Aggregate Bond ETF offers actively managed fixed income at an attractive cost for investors

NEWARK, N.J.–(BUSINESS WIRE)–
PGIM Investments is expanding its exchange-traded fund (ETF) lineup with the launch of the PGIM Active Aggregate Bond ETF (NYSE Arca: PAB). PAB is an actively managed fixed income ETF seeking total return through a combination of current income and capital appreciation. PAB offers core fixed income exposure through a diversified portfolio of investment-grade bonds with an estimated total expense ratio of 0.19%.

“Given the current low-yield environment and potential for increased market volatility, there has been strong client demand for active fixed income solutions,” said Stuart Parker, president and CEO of PGIM Investments. “We are pleased to expand our line-up to include a low-cost active core bond ETF that offers alpha potential with effective risk management via PGIM Fixed Income, one of the largest and most experienced bond managers in the world.”

A Risk-Managed Approach to Active Investing

PGIM Investments’ suite of fixed income ETFs are managed by PGIM Fixed Income, one of the largest and most experienced global fixed income managers in the world, with more than $968 billion in assets under management.1 PGIM Fixed Income’s active investment approach is bolstered by credit research, quantitative research and risk management to help deliver competitive returns and manage volatility.

The PGIM Active Aggregate Bond ETF, managed by senior members of PGIM Fixed Income’s multi-sector team, Richard Piccirillo, Lindsay Rosner and Stewart Wong, includes investment restrictions on characteristics such as duration, quality and sectors in order to manage portfolio risks.

Why Active Fixed Income?

PGIM Investments recently conducted an analysis which found that historically, the majority of active fixed income managers have outperformed their passive peers with a better risk/return profile than the average passive manager. The analysis also found that the Bloomberg Barclays U.S. Aggregate Bond Index (the “Agg”) provides limited sector diversification for investors, as it is heavily weighted toward low-yielding U.S. government debt. While the PGIM Active Aggregate Bond ETF is benchmarked to the Agg, the ETF will seek to invest in a more broadly diversified portfolio across fixed income sectors, industries and issuers.

PGIM Fixed Income’s multi-sector team employs a collaborative bottom-up research-driven security selection process with an intense focus on industry and issuer credit research to extract multiple sources of alpha through active allocations across fixed income spread sectors.

Learn more about PGIM’s suite of actively managed ETFs.

ABOUT PGIM INVESTMENTS

PGIM Investments LLC and its affiliates offer more than 100 funds globally across a broad spectrum of asset classes and investment styles. All products draw on PGIM’s globally diversified investment platform that encompasses the expertise of managers across fixed income, equities and real estate.

ABOUT PGIM

PGIM, the global asset management business of Prudential Financial, Inc. (NYSE: PRU), ranks among the top 10 largest asset managers in the world2 with more than $1.5 trillion in assets under management as of December 31, 2020. With offices in 16 countries, PGIM’s businesses offer a range of investment solutions for retail and institutional investors around the world across a broad range of asset classes, including public fixed income, private fixed income, fundamental equity, quantitative equity, real estate and alternatives. For more information about PGIM, visit pgim.com.

Prudential’s additional businesses offer a variety of products and services, including life insurance, annuities and retirement-related services. For more information about Prudential, please visit news.prudential.com.

 

As of Dec. 31, 2020.

 

Prudential Financial, Inc. (PFI) is the 10th largest investment manager (out of 527 firms surveyed) in terms of global assets under management based on Pensions & Investments’ Top Money Managers list published on June 1, 2020. This ranking represents global assets under management by PFI as of March 31, 2020.

Fund Risk Information

The Fund is an actively managed exchange traded fund (ETF) and, thus, does not seek to replicate the performance of a specified index. The Fund actively and frequently trades its portfolio securities which can result in high portfolio turnover and correspondingly greater transaction and brokerage costs. As an ETF, the Fund’s shares trade on an exchange and are subject to ETF shares trading risk, including that the Fund’s shares may trade at a premium or discount to net asset value; during periods may become less liquid; potentially may lack an active trading market, which may result in significant losses if you sell your shares of the Fund during these periods; and may be subject to authorized participant concentration risk, since the Fund has a limited number of intermediaries that act as authorized participants and none of these authorized participants are or will be obligated to engage in creation or redemption transactions. To the extent that these intermediaries exit the business or are unable to or choose not to proceed with creation and/or redemption orders with respect to the Fund and no other authorized participant creates or redeems, shares of the Fund may trade at a discount to NAV and possibly face trading halts and/or delisting. The Fund may be subject to the risk of increased expenses, meaning that your actual cost of investing in the Fund may be higher than the expense shown in the expense table, as well as the cost of buying or selling shares, since when you buy or sell shares of the Fund through a broker, you will likely incur brokerage commission or other charges; and cash transaction risk, which is the risk that the Fund (which may affect creation and redemptions in cash or partially in cash) may be less tax-efficient than an investment in an ETF that distributes portfolio securities in-kind. As a new and relatively small fund with limited operating history, the Fund is subject to the risk that its performance might not represent how it may perform long term and investments may have disproportionate impact on performance. Fixed income investments are subject to credit, market, and interest rate risks (including duration risk and prepayment risk), and their value will decline as interest rates rise; call and redemption risk, where the issuer may call a bond held by the Fund for redemption before it matures and the Fund may lose income; liquidity risk, which exists when particular investments are difficult to sell; emerging markets risk, which exposes the Fund to greater volatility and price declines. The Fund may invest in foreign securities, which generally involve more risk than investing in U.S. issuers, including political, legal, and economic uncertainty; structured products, which are subject to issuer repayment and counterparty risk; derivatives, which may carry market, credit, and liquidity risks; and mortgage-backed and asset-backed securities, which are subject to prepayment, extension, and interest rate risks. The Fund may be subject to management risk, where the value of your investment may decrease if judgments by the subadviser are incorrect; economic and markets event risk, meaning that events in global financial markets could result in high market volatility, market disruption and geopolitical risks, meaning that international wars or conflicts and geopolitical developments including terrorist attacks and outbreaks of infectious diseases could negatively impact interest rates, market volatility and security pricing, and market risk, where the value of investments may decrease and securities markets are volatile. U.S. government and agency securities and U.S. Treasury bills are backed by the full faith and credit of the U.S. government, are less volatile than equity investments, and provide a guaranteed return of principal at maturity. Large shareholders could subject the Fund to large scale redemption risk. Diversification does not assure a profit or protect against loss in declining markets. These risks may increase the Fund’s share price volatility. The risks associated with the Fund are more fully explained in the prospectus and summary prospectus. There is no guarantee the Fund’s objective will be achieved.

This material is being provided for informational or educational purposes only and does not take into account the investment objectives or financial situation of any client or prospective clients. The information is not intended as investment advice and is not a recommendation. Clients seeking information regarding their particular investment needs should contact a financial professional.

Consider a fund’s investment objectives, risks, charges, and expenses carefully before investing. The prospectus and summary prospectus contain this and other information about the fund. Contact your financial professional for a prospectus and summary prospectus. Read them carefully before investing.

Funds are distributed by Prudential Investment Management Services LLC, a Prudential Financial company. PGIM Fixed Income is an affiliate of PGIM. © 2021 Prudential Financial, Inc. and its related entities. The PGIM logo is a service mark of Prudential Financial, Inc. and its related entities, registered in many jurisdictions worldwide.

Investment products are not insured by the FDIC or any federal government agency, may lose value, and are not a deposit of or guaranteed by any bank or any bank affiliate.

1047094-00001-00

Kylie Scott

973-902-2503

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Other Professional Services Professional Services Insurance Finance

MEDIA:

Logo
Logo